Loading stock data...

Transchem Limited

BSE: TRANSCHEM

BSE
186.60 -3.80 (-2.00%)

Prev Close

190.4

Open Price

186.6

Volume

1,621

Today Low / High

186.6 / 186.6

52 WK Low / High

31.1 / 194.25

Range

177 - 196

The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 186.6, reflecting a change of -3.8 (-1.9958%). The expected target range on the BSE is 177 - 196. The stock is showing a downward trend on the BSE. This could indicate a potential risk for investors who are considering buying at this moment.

07 Jan 186.60 0.00%
06 Jan 190.40 0.00%
05 Jan 194.25 0.00%
02 Jan 190.45 0.00%
01 Jan 186.75 0.00%
31 Dec 183.11 0.00%
30 Dec 179.52 0.00%
29 Dec 178.60 -1.46%
26 Dec 175.10 0.00%
24 Dec 171.67 0.00%
23 Dec 161.90 3.96%
22 Dec 165.52 -0.31%
19 Dec 168.37 0.00%
18 Dec 173.49 -0.97%
17 Dec 170.22 0.00%
16 Dec 166.89 0.00%
15 Dec 163.62 0.00%
12 Dec 155.83 0.00%
11 Dec 148.41 0.00%
10 Dec 141.35 0.00%

Transchem Limited Graph

Transchem Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Transchem Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 186.60, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 186.60 188.47 169.62 - 207.31
190.33 152.27 - 228.40
192.20 134.54 - 249.86
Bearish Scenario 186.60 184.73 166.26 - 203.21
182.87 146.29 - 219.44
181.00 126.70 - 235.30

Overview of Transchem Limited

ISIN

INE019B01010

Industry

Medical - Pharmaceuticals

Vol.Avg

17,871

Market Cap

2,283,984,000

Last Dividend

0

Official Website

Visit Website

IPO Date

2000-02-16

DCF Diff

21.07

DCF

166

Financial Ratios Every Investor Needs

Stock Rating Details for TRANSCHEM

Metric Value Recommendation
Overall Rating B+ Neutral
DCF Score 4 Buy
ROE Score 3 Neutral
ROA Score 4 Buy
Debt-to-Equity (DE) Score 1 Strong Sell
Price-to-Earnings (PE) Score 2 Sell
Price-to-Book (PB) Score 4 Buy

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 2.63 Cr 3.29 Cr -0.65 Cr -0.2489 0.00 Cr 0.46 Cr -1.39 Cr 5.23 Cr 4.27 -1.46 Cr 1.9867
2024-03-31 0.41 Cr 1.16 Cr -0.75 Cr -1.8346 0.00 Cr 0.67 Cr -1.72 Cr 4.20 Cr 3.43 5.66 Cr 10.2522
2023-03-31 0.00 Cr 0.71 Cr -0.71 Cr 0.0000 0.00 Cr 0.62 Cr -1.74 Cr 1.24 Cr 1.01 2.51 Cr 0.0000
2022-03-31 0.00 Cr 0.69 Cr -0.69 Cr 0.0000 0.00 Cr 1.52 Cr -2.75 Cr 2.87 Cr 2.34 3.92 Cr 0.0000
2021-03-31 0.00 Cr 0.81 Cr -0.81 Cr 0.0000 0.21 Cr 0.56 Cr -0.84 Cr 24.15 Cr 19.73 24.89 Cr 0.0000

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 42.34 Cr 79.73 Cr 0.41 Cr 79.3154 Cr 0.00 Cr -42.34 Cr 0.00 Cr 0.05 Cr 0.00 Cr 0.00 Cr 2.04 Cr 0.3011 Cr
2024-03-31 0.32 Cr 76.32 Cr 0.67 Cr 75.6460 Cr 0.00 Cr -0.32 Cr 0.00 Cr 0.09 Cr 0.00 Cr 0.00 Cr 8.91 Cr 0.4790 Cr
2023-03-31 34.50 Cr 66.23 Cr 0.39 Cr 65.8422 Cr 0.00 Cr -34.50 Cr 0.00 Cr 0.09 Cr 0.00 Cr 0.00 Cr 8.23 Cr 0.0898 Cr
2022-03-31 34.22 Cr 66.81 Cr 0.51 Cr 66.3004 Cr 0.00 Cr -34.22 Cr 0.15 Cr 0.10 Cr 0.00 Cr 0.00 Cr 8.82 Cr 0.2796 Cr
2021-03-31 11.71 Cr 63.42 Cr 0.48 Cr 62.9415 Cr 0.00 Cr -11.71 Cr 0.07 Cr 0.11 Cr 0.00 Cr 0.00 Cr 8.69 Cr 0.2553 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2025-03-31 36.0003 Cr 6.0237 Cr 0.0000 Cr 35.9976 Cr 42.0240 Cr 42.3403 Cr -0.0027 Cr 5.2259 Cr 0.0000 Cr 0.0000 Cr 0.0000 Cr
2024-03-31 -39.3063 Cr 5.1236 Cr 0.0000 Cr -39.3093 Cr -34.1827 Cr 0.3163 Cr -0.0030 Cr 4.2034 Cr 0.0000 Cr 0.0000 Cr 0.0000 Cr
2023-03-31 1.2192 Cr -0.9406 Cr 0.0000 Cr 1.2192 Cr 0.2786 Cr 34.4990 Cr 0.0000 Cr 2.5041 Cr 0.0000 Cr 0.0000 Cr 0.1503 Cr
2022-03-31 21.9093 Cr 0.6004 Cr 0.0000 Cr 21.9093 Cr 22.5097 Cr 34.2204 Cr 0.0000 Cr 3.9082 Cr 0.0000 Cr 0.0000 Cr -0.0825 Cr
2021-03-31 -27.7193 Cr 23.0584 Cr 0.0000 Cr -27.8013 Cr -4.6609 Cr 11.7107 Cr -0.0820 Cr 24.7696 Cr 0.0000 Cr 0.0000 Cr 0.0175 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2025-09-30 0.00 Cr 0.00 Cr 0.00 Cr 0.0000 -0.74 Cr 0.68 Cr 0.55 0.93 Cr 0.0000
2025-06-30 0.00 Cr 0.16 Cr -0.16 Cr 0.0000 -0.28 Cr 0.99 Cr 0.81 -0.28 Cr 0.0000
2025-03-31 2.42 Cr 2.40 Cr 0.02 Cr 0.0080 -0.22 Cr 0.73 Cr 0.60 -0.48 Cr 0.3010
2024-12-31 0.21 Cr 0.34 Cr -0.14 Cr -0.6578 -0.34 Cr 1.39 Cr 1.13 1.86 Cr 6.7447
2024-09-30 0.00 Cr 0.54 Cr -0.54 Cr 0.0000 -0.37 Cr 1.44 Cr 1.18 1.94 Cr 0.0000

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2025-09-30 0.88 Cr 0.00 Cr 0.88 Cr 77.44 Cr 0.00 Cr 79.45 Cr 0.05 Cr 81.60 Cr 0.60 Cr
2025-06-30 0.00 Cr 0.00 Cr 42.34 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -79.32 Cr
2025-03-31 42.34 Cr 0.00 Cr 42.34 Cr 2.71 Cr 0.00 Cr 77.64 Cr 0.05 Cr 79.73 Cr 0.41 Cr
2024-12-31 0.00 Cr 0.00 Cr 0.34 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -77.30 Cr
2024-09-30 0.34 Cr 0.00 Cr 0.34 Cr 70.37 Cr 0.00 Cr 72.31 Cr 0.08 Cr 77.99 Cr 0.69 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2025-06-30 0.99 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2025-03-31 0.73 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-12-31 1.39 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-09-30 1.44 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-06-30 1.66 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr

Splits History

Date Label Split Ratio
No split history data available.

Similar Stocks: Medical - Pharmaceuticals

Company Name Symbol Price Market Cap Volume
MedPlus Health Services Limited MEDPLUS ₹833.80 ₹99,862,304,925.00 ₹116,435.00

Key Executives

Whole Time Director
Mahesh Suresh Rananavre

Gender: male

Year Born: 1982

Compliance Officer & Company Secretary
Neeraja Deepak Karandikar

Gender: female

Year Born: 1968

Chief Financial Officer
Sarita Maharao

Gender: female

Year Born:

FAQs about Transchem Limited

Who is the CEO of the company?

The CEO is Mahesh Suresh Rananavre.

What is the current market price of the stock?

The current price is ₹186.60.

What is the 52-week price range?

The range is ₹31.1-194.25.

What is the market capitalization of the company?

The market capitalization is ₹228.40 crores.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is 60.24.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of Transchem Limited (ISIN: INE019B01010) is a leading Medical - Pharmaceuticals in India. With a market capitalization of ₹228.40 crores and an average daily volume of 17,871 shares, it operates in the Medical - Pharmaceuticals. The company last declared a dividend of ₹0.